NDC11 81033012344
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 81033-0123-44 | 81033-0123 |
| 81033-123-44 | 81033-123 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Kesin Pharma Corporation | 4470a567-93a6-a293-e063-6394a90affc1 | 2025-11-25 | Warnings, Adverse reactions | 81033-123 |
| Gabapentin | GABAPENTIN | Kesin Pharma Corporation | 3f2ba3d6-6086-eaf2-e063-6294a90a7642 | 2025-09-19 | Warnings, Adverse reactions | 81033-123-44 81033-123 81033012344 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.